Brady Corporation delivered a strong QQ4 2024, finishing fiscal 2024 with record-high earnings per share and robust cash generation, underpinned by margin expansion and disciplined cost management. Revenue for Q4 2024 was $343.4 million, with gross margin of 51.6% and GAAP EPS of $1.15 (non-GAAP $1.19). Full-year organic sales grew 2.6%, supported by momentum in Americas and Asia (notably India), while Europe faced a more challenging macro backdrop. The Gravotech acquisition closed on August 1, 2023, and Brady signaled meaningful longer-term upside from direct marking capabilities, extended product offerings, and integration synergies, with Gravotech expected to contribute approximately $125 million in revenue and about $13 million of EBITDA in fiscal 2025 (excluding integration costs). Brady is guiding to GAAP EPS of $4.20-$4.45 and non-GAAP EPS of $4.40-$4.70 for fiscal 2025, with organic sales growth in the low-single digits. Management reaffirmed a disciplined capital-allocation framework: fund organic growth and R&D, reward shareholders via dividends and buybacks, and pursue M&A selectively when attractive.